GenePath
A Genetic counselling and pathology initiatives
23/09/2026
We are proud to collaborate with đđđĨđ đđđ§đđđĸđđŦ as country (Bangladesh) partner. âŖ
âŖ
Genetics Essential Training Series 2026 - Session 6âŖ
âŖ
đđđ˛đ¨đ§đ đđđđ: đđđĢđĻđĨđĸđ§đ đđđŦđđĸđ§đ đĸđ§ đđđĢđđđĸđđđĢđ˛ đđĢđđđŦđ đđ§đ đđ¯đđĢđĸđđ§ đđđ§đđđĢâŖ
âŖ
đī¸ Dr. Ervina Kimberly â Medical Affairs, NalaGeneticsâŖ
đī¸ Dr. Syeda Zubeda â Medical Geneticist, Strand Life SciencesâŖ
âŖ
đŖī¸ Moderated by Michael Timothy, Business Development, NalaGeneticsâŖ
âŖ
đ
đ
đĢđĸđđđ˛, đđ đđđŠđđđĻđđđĢ đđđđâŖ
đ 19.00â20.30 WIB / 20.00â21.30 SGTâŖ
đģ Zoom MeetingâŖ
đī¸ Free registration: bit.ly/GET2026âŖ
âŖ
Open to clinicians, genetic counsellors, and anyone working with hereditary cancer risk. We'd be glad to see you there.
GenePath founder Dr. Mustak Ibn Ayub is offering a Course on Molecular Oncology at LifeCourse.
See the post on LifeCourse for registration.
22/08/2026
đđđ§đđđđđĄ đĸđŦ đŠđĨđđđŦđđ đđ¨ đ¨đđđĸđđĸđđĨđĨđ˛ đ°đđĨđđ¨đĻđ đ¨đŽđĢ đ§đđ° đđ¨đĄđ¨đĢđ đ¨đ đĢđđŦđđđĢđđĄ đĸđ§đđđĢđ§đŦ.
âAs we advance our work in genomic research and longitudinal health studies, we recognize that fresh perspectives are essential to our success. At GenePath, we are committed to fostering the next generation of scientists, whose work is vital to understanding the complex intersections of genetics and human health across the lifecourse.
âđđ¨ đ¨đŽđĢ đĸđ§đđđĢđ§đŦ: your contributions are integral to our mission of delivering practical, evidence-based insights for global health. We look forward to your professional growth and the innovative energy you will bring to our laboratory and analytical teams.
â
đđ đ°đĸđŦđĄ đ˛đ¨đŽ đ đŠđĢđ¨đđŽđđđĸđ¯đ đđ§đ đĸđĻđŠđđđđđŽđĨ đđđ§đŽđĢđ đ°đĸđđĄ đŽđŦ.
â
19/08/2026
"āĻā§āύā§āĻāĻŋāĻ āĻāĻžāĻāύā§āϏāĻŋāϞāĻŋāĻ āϏāĻŽā§āĻĒāϰā§āĻā§ āϝāĻž āĻāĻžāύāĻž āĻĒā§āϰā§ā§āĻāύ"
ā§§. āĻā§āύā§āĻāĻŋāĻ āĻāĻžāĻāύā§āϏā§āϞāĻŋāĻ āĻā§?
āĻā§āύā§āĻāĻŋāĻ āĻāĻžāĻāύā§āϏā§āϞāĻŋāĻ (Genetic Counseling) āĻšāϞ⧠āĻāĻŽāύ āĻāĻāĻāĻŋ āϏā§āĻŦāĻžāϏā§āĻĨā§āϝāϏā§āĻŦāĻž āĻĒā§āϰāĻā§āϰāĻŋā§āĻž, āϝā§āĻāĻžāύ⧠āĻāĻāĻāύ āĻĒā§āϰāĻļāĻŋāĻā§āώāĻŋāϤ Genetic Counselor, Clinical Geneticist āĻ
āĻĨāĻŦāĻž āϏāĻāĻļā§āϞāĻŋāώā§āĻ āĻāĻŋāĻāĻŋā§āϏāĻ āϰā§āĻā§ āĻ āϤāĻžāϰ āĻĒāϰāĻŋāĻŦāĻžāϰā§āϰ āĻāĻŋāĻāĻŋā§āϏāĻž-āĻāϤāĻŋāĻšāĻžāϏ, āĻĒāĻžāϰāĻŋāĻŦāĻžāϰāĻŋāĻ āϰā§āĻā§āϰ āĻāϤāĻŋāĻšāĻžāϏ āĻāĻŦāĻ āĻĒā§āϰā§ā§āĻāύ āĻ
āύā§āϝāĻžā§ā§ āĻā§āύā§āĻāĻŋāĻ āĻĒāϰā§āĻā§āώāĻžāϰ āĻĢāϞāĻžāĻĢāϞ āĻŦāĻŋāĻļā§āϞā§āώāĻŖ āĻāϰ⧠āĻā§āύ⧠āϰā§āĻā§āϰ āĻŦāĻāĻļāĻāϤ āĻā§āĻāĻāĻŋ, āϰā§āĻā§āϰ āϏāĻŽā§āĻāĻžāĻŦāύāĻž, āĻā§āύā§āĻāĻŋāĻ āĻĒāϰā§āĻā§āώāĻžāϰ āĻĒā§āϰā§ā§āĻāύā§ā§āϤāĻž āĻ āĻĢāϞāĻžāĻĢāϞā§āϰ āĻ
āϰā§āĻĨ āϏāĻŽā§āĻĒāϰā§āĻā§ āĻŦā§āĻā§āĻāĻžāύāĻŋāĻ āĻ āĻŦā§āϝāĻā§āϤāĻŋāĻā§āύā§āĻĻā§āϰāĻŋāĻ āĻĒāϰāĻžāĻŽāϰā§āĻļ āĻĒā§āϰāĻĻāĻžāύ āĻāϰā§āύāĨ¤
āĻāϰ āĻāĻĻā§āĻĻā§āĻļā§āϝ āĻļā§āϧ⧠āĻā§āύā§āĻāĻŋāĻ āĻĒāϰā§āĻā§āώāĻž āĻāϰāĻžāύ⧠āύā§; āĻŦāϰāĻ āĻĒāϰā§āĻā§āώāĻžāϰ āĻāĻā§ āĻ āĻĒāϰ⧠āϰā§āĻā§āĻā§ āϏāĻ āĻŋāĻ āϤāĻĨā§āϝ āĻĒā§āϰāĻĻāĻžāύ, āϏāĻŽā§āĻāĻžāĻŦā§āϝ āĻā§āĻāĻāĻŋ āĻŦā§āĻāĻžāύ⧠āĻāĻŦāĻ āĻāĻŋāĻāĻŋā§āϏāĻž āĻ āĻāĻŦāĻŋāώā§āϝ⧠āϏā§āĻŦāĻžāϏā§āĻĨā§āϝ-āĻĒāϰāĻŋāĻāϞā§āĻĒāύāĻžā§ āϏāĻšāĻžā§āϤāĻž āĻāϰāĻžāĨ¤
⧍. āĻā§āϝāĻžāύā§āϏāĻžāϰ āĻā§āύā§āĻāĻŋāĻ āĻāĻžāĻāύā§āϏā§āϞāĻŋāĻ āĻŦāϞāϤ⧠āĻā§ āĻŦā§āĻāĻžā§?
āĻā§āϝāĻžāύā§āϏāĻžāϰ āĻā§āύā§āĻāĻŋāĻ āĻāĻžāĻāύā§āϏā§āϞāĻŋāĻ (Cancer Genetic Counseling) āĻšāϞ⧠āĻāĻŽāύ āĻāĻāĻāĻŋ āĻŦāĻŋāĻļā§āώāĻžā§āĻŋāϤ āĻāĻžāĻāύā§āϏā§āϞāĻŋāĻ āĻĒā§āϰāĻā§āϰāĻŋā§āĻž, āϝāĻžāϰ āĻŽāĻžāϧā§āϝāĻŽā§ āĻā§āύ⧠āĻŦā§āϝāĻā§āϤāĻŋāϰ āĻā§āϝāĻžāύā§āϏāĻžāϰ āĻšāĻā§āĻžāϰ āϏāĻŽā§āĻāĻžāĻŦā§āϝ āĻŦāĻāĻļāĻāϤ āĻŦāĻž hereditary risk āĻŽā§āϞā§āϝāĻžā§āύ āĻāϰāĻž āĻšā§āĨ¤
āĻ āĻā§āώā§āϤā§āϰ⧠āϏāĻžāϧāĻžāϰāĻŖāϤ āĻŦā§āϝāĻā§āϤāĻŋāϰ:
āĻŦā§āϝāĻā§āϤāĻŋāĻāϤ āĻā§āϝāĻžāύā§āϏāĻžāϰā§āϰ āĻāϤāĻŋāĻšāĻžāϏ
āĻĒāϰāĻŋāĻŦāĻžāϰā§āϰ āϏāĻĻāϏā§āϝāĻĻā§āϰ āĻā§āϝāĻžāύā§āϏāĻžāϰā§āϰ āĻāϤāĻŋāĻšāĻžāϏ
āĻā§āϝāĻžāύā§āϏāĻžāϰā§āϰ āϧāϰāύ āĻ āĻāĻā§āϰāĻžāύā§āϤ āĻšāĻā§āĻžāϰ āĻŦā§āϏ
āĻāĻāĻžāϧāĻŋāĻ āĻĒā§āϰāĻāύā§āĻŽā§ āĻāĻāĻ āĻŦāĻž āϏāĻŽā§āĻĒāϰā§āĻāĻŋāϤ āĻā§āϝāĻžāύā§āϏāĻžāϰā§āϰ āĻāĻĒāϏā§āĻĨāĻŋāϤāĻŋ
āĻĒā§āϰā§ā§āĻāύ āĻ
āύā§āϝāĻžā§ā§ āĻĒā§āϰā§āĻŦāĻŦāϰā§āϤ⧠āĻā§āύā§āĻāĻŋāĻ āĻĒāϰā§āĻā§āώāĻžāϰ āĻĢāϞāĻžāĻĢāϞ āĻŽā§āϞā§āϝāĻžā§āύ āĻāϰāĻž āĻšā§āĨ¤
āĻĒā§āϰā§ā§āĻāύ⧠BRCA1/BRCA2, TP53, APC, MLH1, MSH2, MSH6, PMS2 āĻāϤā§āϝāĻžāĻĻāĻŋ āĻā§āϝāĻžāύā§āϏāĻžāϰ-āϏāĻŽā§āĻĒāϰā§āĻāĻŋāϤ āĻāĻŋāύā§āϰ āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ āĻĒāϰā§āĻā§āώāĻž āĻŦāĻž multigene panel testing āĻŦāĻŋāĻŦā§āĻāύāĻž āĻāϰāĻž āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤
āϤāĻŦā§ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ āĻŦāĻŋāώ⧠āĻšāϞā§âāĻā§āύā§āĻāĻŋāĻ āĻĒāϰā§āĻā§āώāĻžā§ āĻā§āύ⧠pathogenic variant āĻĒāĻžāĻā§āĻž āĻā§āϞā§āĻ āϝ⧠āĻŦā§āϝāĻā§āϤāĻŋāϰ āĻ
āĻŦāĻļā§āϝāĻ āĻā§āϝāĻžāύā§āϏāĻžāϰ āĻšāĻŦā§, āϤāĻž āύā§āĨ¤ āĻāĻāĻāĻāĻžāĻŦā§, āĻā§āύ⧠variant āύāĻž āĻĒāĻžāĻā§āĻž āĻā§āϞā§āĻ āϏāĻŦ āϧāϰāύā§āϰ āĻā§āϝāĻžāύā§āϏāĻžāϰā§āϰ āĻā§āĻāĻāĻŋ āϏāĻŽā§āĻĒā§āϰā§āĻŖāĻāĻžāĻŦā§ āĻŦāĻžāĻĻ āϝāĻžā§ āύāĻžāĨ¤ āĻĒāϰā§āĻā§āώāĻžāϰ āĻĢāϞāĻžāĻĢāϞ āϰā§āĻā§āϰ āĻŦā§āϝāĻā§āϤāĻŋāĻāϤ āĻ āĻĒāĻžāϰāĻŋāĻŦāĻžāϰāĻŋāĻ āĻāϤāĻŋāĻšāĻžāϏā§āϰ āϏāĻā§āĻā§ āĻŽāĻŋāϞāĻŋā§ā§ Clinical Interpretation āĻāϰāϤ⧠āĻšā§āĨ¤
ā§Š. āĻā§āϝāĻžāύā§āϏāĻžāϰ āĻŦāĻž āĻ
āύā§āϝāĻžāύā§āϝ āĻāĻāĻŋāϞ āϰā§āĻā§āϰ āĻā§āώā§āϤā§āϰ⧠āĻā§āύā§āĻāĻŋāĻ āĻāĻžāĻāύā§āϏā§āϞāĻŋāĻ āĻ āĻā§āϏā§āĻ āĻā§āύ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ?
āĻā§āύā§āĻāĻŋāĻ āĻāĻžāĻāύā§āϏā§āϞāĻŋāĻ āĻ āĻāĻĒāϝā§āĻā§āϤ āĻā§āύā§āĻāĻŋāĻ āĻĒāϰā§āĻā§āώāĻž āĻā§ā§āĻāĻāĻŋ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ āĻāĻžāϰāĻŖā§ āĻāĻŋāĻāĻŋā§āϏāĻžāĻŦā§āϝāĻŦāϏā§āĻĨāĻžā§ āĻŽā§āϞā§āϝāĻŦāĻžāύāĨ¤
āĻ. āϰā§āĻā§āϰ āĻŦāĻāĻļāĻāϤ āĻā§āĻāĻāĻŋ āĻļāύāĻžāĻā§āϤāĻāϰāĻŖ
āĻāĻŋāĻā§ āĻā§āϝāĻžāύā§āϏāĻžāϰ āĻ āĻ
āύā§āϝāĻžāύā§āϝ āĻāĻāĻŋāϞ āϰā§āĻā§āϰ āĻā§āώā§āϤā§āϰ⧠āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ āĻā§āύā§āĻāĻŋāĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ āϰā§āĻā§āϰ āĻā§āĻāĻāĻŋ āĻāϞā§āϞā§āĻāϝā§āĻā§āϝāĻāĻžāĻŦā§ āĻŦā§āĻĻā§āϧāĻŋ āĻāϰāϤ⧠āĻĒāĻžāϰā§āĨ¤ āĻāĻžāĻāύā§āϏā§āϞāĻŋāĻā§ā§āϰ āĻŽāĻžāϧā§āϝāĻŽā§ āĻ āϧāϰāύā§āϰ āĻā§āĻāĻāĻŋ āĻļāύāĻžāĻā§āϤ āĻāϰāĻžāϰ āϏā§āϝā§āĻ āϤā§āϰāĻŋ āĻšā§āĨ¤
āĻ. āϰā§āĻā§āϰ āĻāĻŋāĻāĻŋā§āϏāĻž āĻĒāϰāĻŋāĻāϞā§āĻĒāύāĻžā§ āϏāĻšāĻžā§āϤāĻž
āĻāĻŋāĻā§ āĻā§āώā§āϤā§āϰ⧠āĻā§āύā§āĻāĻŋāĻ āϤāĻĨā§āϝ āϰā§āĻā§āϰ diagnosis, prognosis, treatment selection āĻŦāĻž targeted therapy āϏāĻŽā§āĻĒāϰā§āĻā§ āĻāĻŋāĻāĻŋā§āϏāĻāĻĻā§āϰ āϏāĻŋāĻĻā§āϧāĻžāύā§āϤ āĻā§āϰāĻšāĻŖā§ āϏāĻšāĻžā§āϤāĻž āĻāϰāϤ⧠āĻĒāĻžāϰā§āĨ¤
āĻ. āĻŦā§āϝāĻā§āϤāĻŋāĻā§āύā§āĻĻā§āϰāĻŋāĻ āĻāĻŋāĻāĻŋā§āϏāĻž
Genomic information āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ āϰā§āĻā§āϰ āĻāύā§āϝ āĻāĻĒāϝā§āĻā§āϤ āĻāĻŋāĻāĻŋā§āϏāĻž āĻŦāĻž monitoring strategy āύāĻŋāϰā§āϧāĻžāϰāĻŖā§ āϏāĻšāĻžā§āĻ āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤ āĻŦāĻŋāĻļā§āώ āĻāϰ⧠āĻāĻŋāĻā§ āĻā§āϝāĻžāύā§āϏāĻžāϰ⧠molecular profiling āĻāĻŋāĻāĻŋā§āϏāĻž āύāĻŋāϰā§āĻŦāĻžāĻāύ⧠āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ āĻā§āĻŽāĻŋāĻāĻž āĻĒāĻžāϞāύ āĻāϰā§āĨ¤
āĻ. āĻĒāϰāĻŋāĻŦāĻžāϰā§āϰ āĻ
āύā§āϝāĻžāύā§āϝ āϏāĻĻāϏā§āϝāĻĻā§āϰ āĻā§āĻāĻāĻŋ āĻŽā§āϞā§āϝāĻžā§āύ
āϝāĻĻāĻŋ āĻā§āύ⧠āϰā§āĻā§āϰ āĻŽāϧā§āϝ⧠clinically significant hereditary variant āĻļāύāĻžāĻā§āϤ āĻšā§, āϤāĻžāĻšāϞ⧠āĻĒāϰāĻŋāĻŦāĻžāϰā§āϰ āĻ
āύā§āϝāĻžāύā§āϝ āϏāĻĻāϏā§āϝāĻĻā§āϰāĻ āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ āĻĒāϰāĻŋāϏā§āĻĨāĻŋāϤāĻŋāϤ⧠genetic counseling āĻ testing-āĻāϰ āĻĒā§āϰā§ā§āĻāύ āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤
āĻ. āĻāĻāĻžāĻŽ āĻā§āĻāĻāĻŋ āĻŦā§āϝāĻŦāϏā§āĻĨāĻžāĻĒāύāĻž
āĻāĻā§āĻ āĻā§āĻāĻāĻŋāϰ āĻŦā§āϝāĻā§āϤāĻŋāĻĻā§āϰ āĻā§āώā§āϤā§āϰ⧠āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ āĻĒāϰāĻžāĻŽāϰā§āĻļ āĻ
āύā§āϝāĻžā§ā§ āĻ
āϤāĻŋāϰāĻŋāĻā§āϤ surveillance, screening āĻŦāĻž preventive management āĻā§āϰāĻšāĻŖā§āϰ āϏā§āϝā§āĻ āϤā§āϰāĻŋ āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤
āĻ. āĻ
āĻĒā§āϰā§ā§āĻāύā§ā§ āĻĒāϰā§āĻā§āώāĻž āĻ āĻā§āϞ āϏāĻŋāĻĻā§āϧāĻžāύā§āϤ āĻāĻŽāĻžāϤ⧠āϏāĻšāĻžā§āϤāĻž
Genetic counseling āϰā§āĻā§āĻā§ āĻŦā§āĻāĻžāϤ⧠āϏāĻžāĻšāĻžāϝā§āϝ āĻāϰā§âāĻā§āύ āĻĒāϰā§āĻā§āώāĻž āĻĒā§āϰā§ā§āĻāύ, āĻĒāϰā§āĻā§āώāĻžāϰ āϏā§āĻŽāĻžāĻŦāĻĻā§āϧāϤāĻž āĻā§ āĻāĻŦāĻ āĻāĻāĻāĻŋ genetic test-āĻāϰ āĻĢāϞāĻžāĻĢāϞ āĻā§āĻāĻžāĻŦā§ āĻŦā§āϝāĻžāĻā§āϝāĻž āĻāϰāϤ⧠āĻšāĻŦā§āĨ¤ āĻĢāϞ⧠āĻļā§āϧā§āĻŽāĻžāϤā§āϰ āĻāĻāĻāĻŋ āϰāĻŋāĻĒā§āϰā§āĻā§āϰ āĻāĻĒāϰ āĻāĻŋāϤā§āϤāĻŋ āĻāϰ⧠āĻā§āϞ āϏāĻŋāĻĻā§āϧāĻžāύā§āϤ āύā§āĻā§āĻžāϰ āĻā§āĻāĻāĻŋ āĻāĻŽā§āĨ¤
ā§Ē. āĻā§āύā§āĻāĻŋāĻ āĻāĻžāĻāύā§āϏā§āϞāĻŋāĻ āĻāĻŋ āϏāϰāĻžāϏāϰāĻŋ āĻāĻŋāĻāĻŋā§āϏāĻž āĻĒā§āϰāĻā§āϰāĻŋā§āĻž?
āĻā§āύā§āĻāĻŋāĻ āĻāĻžāĻāύā§āϏā§āϞāĻŋāĻ āύāĻŋāĻā§ āϏāĻžāϧāĻžāϰāĻŖāϤ āϰā§āĻā§āϰ āϏāϰāĻžāϏāϰāĻŋ āĻāĻŋāĻāĻŋā§āϏāĻž āύā§āĨ¤ āĻāĻāĻŋ āĻāĻāĻāĻŋ clinical decision-support āĻāĻŦāĻ risk-assessment service, āϝāĻž āϰā§āĻ āύāĻŋāϰā§āĻŖā§, āĻā§āĻāĻāĻŋ āĻŽā§āϞā§āϝāĻžā§āύ, āĻāĻŋāĻāĻŋā§āϏāĻž āύāĻŋāϰā§āĻŦāĻžāĻāύ āĻāĻŦāĻ āĻāĻŦāĻŋāώā§āϝ⧠āϏā§āĻŦāĻžāϏā§āĻĨā§āϝ āĻŦā§āϝāĻŦāϏā§āĻĨāĻžāĻĒāύāĻžāϰ āϏāĻā§āĻā§ āϏāĻŽāύā§āĻŦāĻŋāϤāĻāĻžāĻŦā§ āĻĒāϰāĻŋāĻāĻžāϞāĻŋāϤ āĻšā§āĨ¤
āĻ
āϰā§āĻĨāĻžā§, āĻā§āύā§āĻāĻŋāĻ āĻāĻžāĻāύā§āϏā§āϞāĻŋāĻāĻā§ āĻāĻŋāĻāĻŋā§āϏāĻžāϰ āĻŦāĻŋāĻāϞā§āĻĒ āĻšāĻŋāϏā§āĻŦā§ āĻĻā§āĻāĻž āĻāĻāĻŋāϤ āύā§āĨ¤ āĻŦāϰāĻ āĻĒā§āϰā§ā§āĻāύ āĻ
āύā§āϝāĻžā§ā§ āĻāĻāĻŋ āϰā§āĻā§āϰ āĻŽā§āϞ āĻāĻŋāĻāĻŋā§āϏāĻž āĻŦā§āϝāĻŦāϏā§āĻĨāĻžāϰ āĻ
āĻāĻļ āĻšāĻŋāϏā§āĻŦā§ āĻŦāĻž āĻĒāĻžāĻļāĻžāĻĒāĻžāĻļāĻŋ āϧāĻžāϰāĻžāĻŦāĻžāĻšāĻŋāĻāĻāĻžāĻŦā§ āĻĒāϰāĻŋāĻāĻžāϞāύāĻž āĻāϰāĻž āĻ
āϧāĻŋāĻ āĻāĻžāϰā§āϝāĻāϰāĨ¤
āĻāĻĻāĻžāĻšāϰāĻŖāϏā§āĻŦāϰā§āĻĒ, āĻā§āϝāĻžāύā§āϏāĻžāϰā§āϰ āĻā§āώā§āϤā§āϰ⧠āĻāĻāĻāύ āϰā§āĻā§ āĻĒā§āϰāĻĨāĻŽā§ āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ āĻŽāĻžāϧā§āϝāĻŽā§ clinical evaluation-āĻāϰ āĻĒāϰ genetic counseling āĻĒā§āϤ⧠āĻĒāĻžāϰā§āύāĨ¤ āĻāĻžāĻāύā§āϏā§āϞāĻŋāĻā§ā§āϰ āĻŽāĻžāϧā§āϝāĻŽā§ āĻĒāϰā§āĻā§āώāĻžāϰ āĻĒā§āϰā§ā§āĻāύā§ā§āϤāĻž āύāĻŋāϰā§āϧāĻžāϰāĻŖ āĻāϰāĻž āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤ āĻĒāϰā§āĻā§āώāĻž āĻāϰāĻž āĻšāϞ⧠āϤāĻžāϰ āĻĢāϞāĻžāĻĢāϞ āĻĒā§āύāϰāĻžā§ clinical context-āĻ āĻŦā§āϝāĻžāĻā§āϝāĻž āĻāϰāĻž āĻšā§ āĻāĻŦāĻ āĻĒā§āϰā§ā§āĻāύ āĻ
āύā§āϝāĻžā§ā§ oncologist, clinical geneticist, surgeon āĻŦāĻž āĻ
āύā§āϝāĻžāύā§āϝ āĻŦāĻŋāĻļā§āώāĻā§āĻā§āϰ āϏāĻā§āĻā§ āϏāĻŽāύā§āĻŦā§ āĻāϰ⧠āĻĒāϰāĻŦāϰā§āϤ⧠āĻŦā§āϝāĻŦāϏā§āĻĨāĻžāĻĒāύāĻž āύāĻŋāϰā§āϧāĻžāϰāĻŖ āĻāϰāĻž āĻšā§āĨ¤
16/08/2026
āĻļā§āĻā§āϰāĻžāĻŖā§āϰ DNA Fragmentation āĻ āĻŦāĻžāϰāĻŦāĻžāϰ āĻāϰā§āĻāĻĒāĻžāϤ: āĻĒā§āϰā§āώā§āϰ āĻĒā§āϰāĻāύāύāϏā§āĻŦāĻžāϏā§āĻĨā§āϝā§āϰ āĻā§āϰā§āϤā§āĻŦ
⧍ā§Ļ⧍ā§Ē āϏāĻžāϞā§āϰ āĻā§āϰā§āώā§āĻŽā§ āĻĢāĻžāϰā§āĻāĻŋāϞāĻŋāĻāĻŋ āĻŦāĻŋāĻļā§āώāĻā§āĻ āĻĄ. āĻā§āϝāĻžāϰāĻŋ āĻŦā§āĻĄāĻŋāϝāĻŧā§āύā§āĻ āϤāĻžāĻāϰ āĻā§āϞāĻŋāύāĻŋāĻā§ āĻāĻ āϤāϰā§āĻŖ āĻĻāĻŽā§āĻĒāϤāĻŋāϰ āϏāĻā§āĻā§ āĻŦāϏā§āĻāĻŋāϞā§āύāĨ¤ āĻĻā§āĻāύā§āϰ āĻŦā§āϏāĻ āĻāĻŋāϞ ā§Šā§¨ āĻŦāĻāϰāĨ¤ āĻĒā§āϰāĻžā§ āĻĒāĻžāĻāĻ āĻŦāĻāϰ āϧāϰ⧠āϤāĻžāĻāϰāĻž āϏāύā§āϤāĻžāύ āύā§āĻā§āĻžāϰ āĻā§āώā§āĻāĻž āĻāϰāĻāĻŋāϞā§āύāĨ¤ āĻāϰ āĻŽāϧā§āϝ⧠āĻāĻāĻžāϧāĻŋāĻāĻŦāĻžāϰ IVF āĻāϰāĻŋā§ā§āĻā§āύ, āĻāĻŋāύā§āϤ⧠āĻā§āύā§āĻŦāĻžāϰāĻ āĻāĻžāĻā§āĻā§āώāĻŋāϤ āĻĢāϞ āĻĒāĻžāύāύāĻŋāĨ¤ āĻāĻāύ⧠āĻā§āϰā§āĻŖ āĻāϰāĻžā§ā§āϤ⧠āĻ āĻŋāĻāĻāĻžāĻŦā§ āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§āύāĻŋ, āĻāĻāύ⧠āĻāϰā§āĻāϧāĻžāϰāĻŖā§āϰ āĻĒāϰ āĻā§āĻŦ āĻĻā§āϰā§āϤāĻ āĻāϰā§āĻāĻĒāĻžāϤ āĻšā§ā§āĻā§āĨ¤ āĻŦāĻžāϰāĻŦāĻžāϰ āĻŦā§āϝāϰā§āĻĨāϤāĻžāϰ āĻĒāϰ āϏā§āĻŦāĻžāĻāĻžāĻŦāĻŋāĻāĻāĻžāĻŦā§āĻ āϤāĻžāĻāĻĻā§āϰ āĻŽāϧā§āϝ⧠āĻšāϤāĻžāĻļāĻž āĻ āĻ
āύāĻŋāĻļā§āĻā§āϤāĻž āϤā§āϰāĻŋ āĻšā§ā§āĻāĻŋāϞāĨ¤
āĻ āϏāĻŽā§ āĻĒāϰā§āϝāύā§āϤ āĻĻāĻŽā§āĻĒāϤāĻŋāϰ āĻĒā§āϰāĻžā§ āϏāĻŦ āĻĒā§āϰāĻāϞāĻŋāϤ āĻĒāϰā§āĻā§āώāĻžāĻ āĻāϰāĻž āĻšā§ā§ āĻāĻŋā§ā§āĻāĻŋāϞāĨ¤ āϰāĻā§āϤ āĻĒāϰā§āĻā§āώāĻž, āĻļā§āĻā§āϰāĻžāĻŖā§āϰ āϏāĻāĻā§āϝāĻž āĻ āĻāϤāĻŋāĻļā§āϞāϤāĻž āĻĒāϰā§āĻā§āώāĻž, āĻāĻŽāύāĻāĻŋ āύāĻžāϰā§āϰ āĻāϰāĻžā§ā§āϰ āĻāĻ āύāĻ āĻĒāϰā§āĻā§āώāĻž āĻāϰāĻž āĻšā§ā§āĻāĻŋāϞāĨ¤ āĻāĻŋāύā§āϤ⧠āĻā§āύ⧠āĻĒāϰā§āĻā§āώāĻžāĻ āϏāĻŽāϏā§āϝāĻžāĻāĻŋāϰ āĻĒāϰāĻŋāώā§āĻāĻžāϰ āĻŦā§āϝāĻžāĻā§āϝāĻž āĻĻāĻŋāϤ⧠āĻĒāĻžāϰāĻāĻŋāϞ āύāĻžāĨ¤
āϤāĻāύ āĻŦā§āĻĄāĻŋāϝāĻŧā§āύā§āĻ āĻāĻāĻā§ āĻāĻŋāύā§āύāĻāĻžāĻŦā§ āĻāĻžāĻŦāϞā§āύāĨ¤ āϤāĻŋāύāĻŋ āĻĒā§āϰā§āώ āϏāĻā§āĻā§āϰ āĻļā§āĻā§āϰāĻžāĻŖā§āϰ DNA fragmentation āĻĒāϰā§āĻā§āώāĻž āĻāϰāĻžāϰ āϏāĻŋāĻĻā§āϧāĻžāύā§āϤ āύāĻŋāϞā§āύāĨ¤ āĻĒāϰā§āĻā§āώāĻžā§ āĻĻā§āĻāĻž āĻā§āϞ, āϤāĻžāĻāϰ āĻļā§āĻā§āϰāĻžāĻŖā§āϤ⧠āĻŽāĻžāĻāĻžāϰāĻŋ āĻŽāĻžāϤā§āϰāĻžāϰ DNA āĻā§āώāϤāĻŋ āϰā§ā§āĻā§āĨ¤
āĻāϰāĻĒāϰ āĻāĻŋāĻāĻŋā§āϏāĻžāϰ āĻ
āĻāĻļ āĻšāĻŋāϏā§āĻŦā§ āϤāĻžāĻāĻā§ āĻā§āĻŦāύāϝāĻžāϤā§āϰāĻžā§ āĻāĻŋāĻā§ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ āĻāύāĻžāϰ āĻĒāϰāĻžāĻŽāϰā§āĻļ āĻĻā§āĻā§āĻž āĻšā§āĨ¤ āϤāĻŋāύāĻŋ āϧā§āĻŽāĻĒāĻžāύ āĻ āĻŽāĻĻā§āϝāĻĒāĻžāύ āĻŦāύā§āϧ āĻāϰā§āύ, āύāĻŋā§āĻŽāĻŋāϤ āĻŦā§āϝāĻžā§āĻžāĻŽ āĻļā§āϰ⧠āĻāϰā§āύ āĻāĻŦāĻ āĻāĻŋāĻāĻžāĻŽāĻŋāύ āϏāĻžāĻĒā§āϞāĻŋāĻŽā§āύā§āĻ āĻā§āϰāĻšāĻŖ āĻāϰā§āύāĨ¤ āĻĒā§āϰāĻžā§ āĻā§ āĻŽāĻžāϏ āĻĒāϰ āĻĻāĻŽā§āĻĒāϤāĻŋ āĻāĻŦāĻžāϰ IVF-āĻāϰ āĻŽāĻžāϧā§āϝāĻŽā§ āĻā§āϰā§āĻŖ āϤā§āϰāĻŋ āĻāϰā§āύāĨ¤ āĻāĻŦāĻžāϰ āĻāϞā§āĻĒāĻāĻž āĻ
āύā§āϝāϰāĻāĻŽ āĻāĻŋāϞāĨ¤ āĻļā§āώ āĻĒāϰā§āϝāύā§āϤ āϤāĻžāĻāĻĻā§āϰ āĻāĻāĻāĻŋ āϏā§āϏā§āĻĨ āĻĒā§āϤā§āϰāϏāύā§āϤāĻžāύ āĻāύā§āĻŽ āύā§ā§āĨ¤
āĻāĻ āĻāĻāύāĻž āĻāĻāĻāĻŋ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ āĻŦāĻŋāώ⧠āϏāĻžāĻŽāύ⧠āύāĻŋā§ā§ āĻāϏā§âāϏāύā§āϤāĻžāύ āϧāĻžāϰāĻŖā§āϰ āϏāĻŽāϏā§āϝāĻžāĻā§ āĻļā§āϧ⧠āύāĻžāϰā§āϰ āĻĻāĻŋāĻ āĻĨā§āĻā§ āĻĻā§āĻāϞ⧠āĻĒā§āϰ⧠āĻāĻŋāϤā§āϰāĻāĻŋ āĻĒāĻžāĻā§āĻž āϝāĻžā§ āύāĻžāĨ¤
āϏāĻžāϧāĻžāϰāĻŖāϤ āĻĒā§āϰā§āώā§āϰ āĻŦāύā§āϧā§āϝāĻžāϤā§āĻŦ āĻŽā§āϞā§āϝāĻžā§āύā§āϰ āϏāĻŽā§ āĻŦā§āϰā§āϝā§āϰ āĻĒāϰāĻŋāĻŽāĻžāĻŖ, āĻļā§āĻā§āϰāĻžāĻŖā§āϰ āϏāĻāĻā§āϝāĻž, āĻāĻ āύ āĻāĻŦāĻ āĻāϤāĻŋāĻļā§āϞāϤāĻž āĻĒāϰā§āĻā§āώāĻž āĻāϰāĻž āĻšā§āĨ¤ āĻāĻŋāύā§āϤ⧠āĻāϏāĻŦ āĻĒāϰā§āĻā§āώāĻžā§ āĻļā§āĻā§āϰāĻžāĻŖā§āϰ āĻā§āϤāϰā§āϰ DNA āĻāϤāĻāĻž āĻ
āĻā§āώāϤ āĻāĻā§, āϏā§āĻāĻŋ āϏāĻŦāϏāĻŽā§ āĻŦā§āĻāĻž āϝāĻžā§ āύāĻžāĨ¤ āĻ
āĻĨāĻ āϏāĻžāĻŽā§āĻĒā§āϰāϤāĻŋāĻ āĻāĻŦā§āώāĻŖāĻžāĻā§āϞ⧠āĻāĻā§āĻāĻŋāϤ āĻĻāĻŋāĻā§āĻā§ āϝ⧠āĻļā§āĻā§āϰāĻžāĻŖā§āϰ DNA-āϤ⧠āĻ
āϤāĻŋāϰāĻŋāĻā§āϤ āĻā§āώāϤāĻŋ āĻĨāĻžāĻāϞ⧠āĻāϰā§āĻāĻĒāĻžāϤā§āϰ āĻā§āĻāĻāĻŋ āĻŦāĻžā§āϤ⧠āĻĒāĻžāϰā§, IVF-āĻāϰ āϏāĻĢāϞāϤāĻž āĻāĻŽāϤ⧠āĻĒāĻžāϰ⧠āĻāĻŦāĻ āĻā§āϰā§āĻŖā§āϰ āĻĒā§āϰāĻžāĻĨāĻŽāĻŋāĻ āĻŦāĻŋāĻāĻžāĻļ āĻŦā§āϝāĻžāĻšāϤ āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤
āĻļā§āĻā§āϰāĻžāĻŖā§āϰ DNA āĻā§āύ āĻā§āώāϤāĻŋāĻā§āϰāϏā§āϤ āĻšā§, āϤāĻžāϰāĻ āĻāĻāĻ āĻā§āύ⧠āĻāϤā§āϤāϰ āύā§āĻāĨ¤ āĻŦā§āϏ, āϧā§āĻŽāĻĒāĻžāύ, āĻŽāĻĻā§āϝāĻĒāĻžāύ, āĻāĻŋāĻā§ āĻŽāĻžāĻĻāĻ, āĻĒāϰāĻŋāĻŦā§āĻļāĻāϤ āĻŦāĻŋāώāĻžāĻā§āϤ āĻĒāĻĻāĻžāϰā§āĻĨ āĻāĻŦāĻ āĻŦāĻŋāĻāĻŋāύā§āύ āĻā§āĻŦāύāϝāĻžāĻĒāύ-āϏāĻŽā§āĻĒāϰā§āĻāĻŋāϤ āĻāĻžāϰāĻŖ āĻāϰ āϏāĻā§āĻā§ āϝā§āĻā§āϤ āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤ āϤāĻŦā§ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ āĻŦāĻŋāώ⧠āĻšāϞā§âāϏāĻŦ āĻā§āώā§āϤā§āϰ⧠DNA āĻā§āώāϤāĻŋāϰ āĻāĻžāϰāĻŖ āĻŦāĻž āĻāϰ āĻāĻŋāĻāĻŋā§āϏāĻž āĻā§ āĻšāĻā§āĻž āĻāĻāĻŋāϤ, āϤāĻž āĻāĻāύ⧠āĻĒā§āϰā§āĻĒā§āϰāĻŋ āĻĒāϰāĻŋāώā§āĻāĻžāϰ āύā§āĨ¤
āĻāĻ āĻāĻžāϰāĻŖā§āĻ s***m DNA fragmentation test āĻāĻāύ⧠āϏāĻŦāĻžāϰ āĻāύā§āϝ āύāĻŋā§āĻŽāĻŋāϤ āĻĒāϰā§āĻā§āώāĻž āĻšāĻŋāϏā§āĻŦā§ āĻŦāĻŋāĻŦā§āĻāĻŋāϤ āĻšā§ āύāĻžāĨ¤ āϤāĻŦā§ āĻāĻŋāĻāĻŋā§āϏāĻžāĻŦāĻŋāĻā§āĻāĻžāύ āϧā§āϰ⧠āϧā§āϰ⧠āĻāϰ āĻā§āϰā§āϤā§āĻŦāĻā§ āϏā§āĻŦā§āĻāĻžāϰ āĻāϰāĻā§āĨ¤ American Society for Reproductive Medicine (ASRM)-āĻāϰ āĻšāĻžāϞāύāĻžāĻāĻžāĻĻ āύāĻŋāϰā§āĻĻā§āĻļāĻŋāĻāĻžā§ āĻŦāĻžāϰāĻŦāĻžāϰ āĻāϰā§āĻāĻĒāĻžāϤā§āϰ āĻā§āώā§āϤā§āϰ⧠āĻāĻ āĻĒāϰā§āĻā§āώāĻž āĻŦāĻŋāĻŦā§āĻāύāĻž āĻāϰāĻž āϝā§āϤ⧠āĻĒāĻžāϰ⧠āĻŦāϞ⧠āĻāϞā§āϞā§āĻ āĻāϰāĻž āĻšā§ā§āĻā§āĨ¤ āĻāĻāĻ āϏāĻā§āĻā§ āϤāĻžāϰāĻž āϏāϤāϰā§āĻ āĻāϰā§āĻā§ āϝ⧠DNA fragmentation āĻāĻŽāĻžāύā§āϰ āĻŽāĻžāϧā§āϝāĻŽā§ āĻāϰā§āĻāϧāĻžāϰāĻŖā§āϰ āĻĢāϞāĻžāĻĢāϞ āύāĻŋāĻļā§āĻāĻŋāϤāĻāĻžāĻŦā§ āĻāύā§āύāϤ āĻšā§ āĻāĻŋ āύāĻž, āϤāĻž āĻāĻžāύāϤ⧠āĻāϰāĻ āĻāĻŦā§āώāĻŖāĻž āĻĒā§āϰā§ā§āĻāύāĨ¤
āĻāĻāĻžāύ⧠āϏāĻŦāĻā§ā§ā§ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ āĻĒāϰāĻŋāĻŦāϰā§āϤāύāĻāĻŋ āϏāĻŽā§āĻāĻŦāϤ āĻĻā§āώā§āĻāĻŋāĻāĻā§āĻāĻŋāϰāĨ¤ āĻŦāĻšā§ āĻŦāĻāϰ āϧāϰ⧠āĻŦāύā§āϧā§āϝāĻžāϤā§āĻŦ āĻ āĻāϰā§āĻāĻĒāĻžāϤā§āϰ āĻāϞā§āĻāύāĻžā§ āύāĻžāϰā§āϰ āĻļāϰā§āϰ āĻ āϏā§āĻŦāĻžāϏā§āĻĨā§āϝā§āϰ āĻāĻĒāϰ āĻŦā§āĻļāĻŋ āĻā§āϰā§āϤā§āĻŦ āĻĻā§āĻā§āĻž āĻšā§ā§āĻā§āĨ¤ āĻāĻŋāύā§āϤ⧠āĻŦāĻžāϏā§āϤāĻŦā§ āϏāύā§āϤāĻžāύ āϧāĻžāϰāĻŖ āĻāĻāĻāĻŋ āĻĻā§āĻ āĻĒāĻā§āώā§āϰ āĻĒā§āϰāĻāύāύ āĻĒā§āϰāĻā§āϰāĻŋā§āĻžāĨ¤ American Urological Association-āĻāϰ āϤāĻĨā§āϝ āĻ
āύā§āϝāĻžā§ā§, āĻĒā§āϰāĻžā§ ā§¨ā§Ļ āĻļāϤāĻžāĻāĻļ āĻŦāύā§āϧā§āϝāĻžāϤā§āĻŦā§āϰ āĻā§āώā§āϤā§āϰ⧠āĻļā§āϧā§āĻŽāĻžāϤā§āϰ āĻĒā§āϰā§āώā§āϰ āĻāĻžāϰāĻŖ āĻĻāĻžā§ā§, āĻāϰ āĻāϰāĻ ā§Šā§Ļâā§Ēā§Ļ āĻļāϤāĻžāĻāĻļ āĻā§āώā§āϤā§āϰ⧠āύāĻžāϰ⧠āĻ āĻĒā§āϰā§āώ āĻāĻā§ā§āϰ āĻāĻžāϰāĻŖ āĻā§āĻŽāĻŋāĻāĻž āϰāĻžāĻā§āĨ¤
āĻļā§āĻā§āϰāĻžāĻŖā§āϰ DNA-āĻā§ āĻ
āύā§āĻāĻāĻž āĻāĻāĻāĻŋ āύāĻŋāϰā§āĻĻā§āĻļāĻŋāĻāĻž āĻŦāĻā§ā§āϰ āϏāĻā§āĻā§ āϤā§āϞāύāĻž āĻāϰāĻž āϝāĻžā§āĨ¤ āĻŦāĻāĻāĻŋ āĻŦāĻžāĻāϰ⧠āĻĨā§āĻā§ āĻ āĻŋāĻāĻ āĻžāĻ āĻĻā§āĻāĻžāϞā§āĻ āĻā§āϤāϰ⧠āϝāĻĻāĻŋ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ āĻāĻžā§āĻāĻžā§ āĻ
āύā§āĻ āĻā§āϞ āĻĨāĻžāĻā§, āϤāĻžāĻšāϞ⧠āύāĻŋāώā§āĻ āĻāĻāϞā§āĻ āĻā§āϰā§āĻŖā§āϰ āϏā§āĻŦāĻžāĻāĻžāĻŦāĻŋāĻ āĻŦāĻŋāĻāĻžāĻļ āĻŦāĻžāϧāĻžāĻā§āϰāϏā§āϤ āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤ āĻ
āϰā§āĻĨāĻžā§, āĻļā§āϧ⧠āĻļā§āĻā§āϰāĻžāĻŖā§ āĻĄāĻŋāĻŽā§āĻŦāĻžāĻŖā§āϤ⧠āĻĒā§āĻāĻāĻžāϤ⧠āĻĒāĻžāϰāϞā§āĻ āϏāĻŦāĻāĻŋāĻā§ āĻ āĻŋāĻ āĻāĻā§âāĻāĻŽāύāĻāĻž āϧāϰ⧠āύā§āĻā§āĻž āϝāĻžā§ āύāĻžāĨ¤
āϤāĻŦā§ āĻāĻ āĻŦāĻŋāώā§āĻāĻŋāϰ āĻāϰā§āĻāĻāĻŋ āĻŽāĻžāύāĻŦāĻŋāĻ āĻĻāĻŋāĻāĻ āϰā§ā§āĻā§āĨ¤ āĻŦāύā§āϧā§āϝāĻžāϤā§āĻŦāĻā§ āĻ
āύā§āĻ āϏāĻŽāĻžāĻā§ āĻāĻāύ⧠āĻĒā§āϰā§āώāϤā§āĻŦ āĻŦāĻž āύāĻžāϰā§āϤā§āĻŦā§āϰ āϏāĻā§āĻā§ āĻā§āĻŋā§ā§ āĻĻā§āĻāĻž āĻšā§āĨ¤ āĻŦāĻŋāĻļā§āώ āĻāϰ⧠āĻĒā§āϰā§āώāĻĻā§āϰ āĻā§āώā§āϤā§āϰ⧠āϏāύā§āϤāĻžāύ āĻāύā§āĻŽāĻĻāĻžāύā§āϰ āϏāĻā§āώāĻŽāϤāĻžāĻā§ āĻ
āύā§āĻ āϏāĻŽā§ āĻĒā§āϰā§āώāϤā§āĻŦā§āϰ āĻŽāĻžāĻĒāĻāĻžāĻ āĻŋ āĻšāĻŋāϏā§āĻŦā§ āĻŦāĻŋāĻŦā§āĻāύāĻž āĻāϰāĻž āĻšā§āĨ¤ āĻĢāϞ⧠āϏāύā§āϤāĻžāύ āύāĻž āĻšāϞ⧠āĻ
āύā§āĻ āĻĒā§āϰā§āώāĻ āϞāĻā§āĻāĻž, āĻ
āĻĒāϰāĻžāϧāĻŦā§āϧ āĻŦāĻž āĻŽāĻžāύāϏāĻŋāĻ āĻāĻžāĻĒā§ āĻā§āĻā§āύāĨ¤
āϤāĻžāĻ āĻŦāύā§āϧā§āϝāĻžāϤā§āĻŦ āĻŦāĻž āĻŦāĻžāϰāĻŦāĻžāϰ āĻāϰā§āĻāĻĒāĻžāϤāĻā§ āĻļā§āϧ⧠āύāĻžāϰā§āϰ āϏāĻŽāϏā§āϝāĻž āĻšāĻŋāϏā§āĻŦā§ āĻĻā§āĻāĻžāϰ āϏāĻŽā§ āϏāĻŽā§āĻāĻŦāϤ āĻļā§āώ āĻšā§ā§ āĻāϏāĻā§āĨ¤ āϏāύā§āϤāĻžāύ āϧāĻžāϰāĻŖā§āϰ āĻĒāĻĨā§ āύāĻžāϰ⧠āĻ āĻĒā§āϰā§āώâāĻĻā§āĻāύā§āϰ āĻĒā§āϰāĻāύāύāϏā§āĻŦāĻžāϏā§āĻĨā§āϝā§āϰāĻ āĻā§āϰā§āϤā§āĻŦ āϰā§ā§āĻā§āĨ¤ āĻļā§āĻā§āϰāĻžāĻŖā§āϰ DNA āύāĻŋā§ā§ āύāϤā§āύ āĻāĻŦā§āώāĻŖāĻžāĻā§āϞ⧠āϏā§āĻ āĻāĻĒāϞāĻŦā§āϧāĻŋāĻā§āĻ āĻāϰāĻ āĻļāĻā§āϤāĻŋāĻļāĻžāϞ⧠āĻāϰāĻā§āĨ¤
āϤāĻŦā§ āĻāĻāĻŋāĻ āĻŽāύ⧠āϰāĻžāĻāĻž āĻāϰā§āϰāĻŋ āϝ⧠s***m DNA fragmentation āĻāĻāĻāĻŋ āϏāĻŽā§āĻāĻžāĻŦā§āϝ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ āĻŦāĻŋāώ⧠āĻšāϞā§āĻ āĻāĻāĻŋ āĻŦāύā§āϧā§āϝāĻžāϤā§āĻŦ āĻŦāĻž āĻāϰā§āĻāĻĒāĻžāϤā§āϰ āĻāĻāĻŽāĻžāϤā§āϰ āĻāĻžāϰāĻŖ āύā§āĨ¤ āĻ āĻŦāĻŋāώā§ā§ āĻāĻŦā§āώāĻŖāĻž āĻāĻāύāĻ āĻāϞāĻā§ āĻāĻŦāĻ āĻĒāϰā§āĻā§āώāĻžāϰ āĻĢāϞāĻžāĻĢāϞāĻā§ āϏāĻŦāϏāĻŽā§ āĻĻāĻŽā§āĻĒāϤāĻŋāϰ āϏāĻžāĻŽāĻā§āϰāĻŋāĻ āĻāĻŋāĻāĻŋā§āϏāĻž āĻāϤāĻŋāĻšāĻžāϏā§āϰ āϏāĻā§āĻā§ āĻŽāĻŋāϞāĻŋā§ā§āĻ āĻŽā§āϞā§āϝāĻžā§āύ āĻāϰāĻž āĻāĻāĻŋāϤāĨ¤
āϤāĻĨā§āϝāϏā§āϤā§āϰ: Scientific American
# āĻŦāύā§āϧā§āϝāĻžāϤā§āĻŦ # DNA_Fragmentation
09/08/2026
āĻāϤāĻāĻžāϞ ā§Ž āĻāĻāώā§āĻ GenePath āĻāϰ āϏāĻšāϝā§āĻā§āϤāĻžā§ iNQUEST āĻ NYBB āĻāϰ āĻāĻĻā§āϝā§āĻā§ GenePath Centre āĻ Intensive Hands on Training Course on "Metaginomics Data Analyse" āĻļā§āϰā§āώāĻ āĻļāĻŋāϰā§āύāĻžāĻŽā§ Inquest-NYBB Omics Training Series-2026 āϏāĻĢāϞāĻāĻžāĻŦā§ āĻ
āύā§āώā§āĻ āĻŋāϤ āĻšā§ā§āĻā§āĨ¤
āϏāĻžāϰāĻž āĻĻā§āĻļā§āϰ āĻŦāĻŋāĻāĻŋāύā§āύ āĻĒā§āϰāϤāĻŋāώā§āĻ āĻžāύā§āϰ āĻļāĻŋāĻā§āώāĻžāϰā§āĻĨā§ āĻ āϤāϰā§āĻŖ āĻāĻŦā§āώāĻāĻāĻŖ āĻāĻĒāϏā§āĻĨāĻŋāϤ āĻāĻŋāϞā§āύāĨ¤ āĻĻā§āĻļā§āϰ āϤāϰā§āĻŖāĻĻā§āϰ āĻāĻŦā§āώāĻŖāĻžāϰ āĻŽā§āϞāĻŋāĻ āĻļāĻŋāĻā§āώāĻžāĻĻāĻžāύ āĻ āĻāĻŦā§āώāĻŖāĻžāϰ āϏā§āϝā§āĻ āϤā§āϰāĻŋāϤ⧠GenePath āĻ
āĻā§āϰāĻŖā§ āĻā§āĻŽāĻŋāĻāĻž āĻĒāĻžāϞāύ āĻāϰ⧠āϝāĻžāĻŦā§āĨ¤
27/07/2026
⧍ā§Ģ āĻā§āϞāĻžāĻ, ⧍ā§Ļ⧍ā§Ŧ āĻāĻŋāύāĻĒāĻžāĻĨ (GenePath)-āĻāϰ āĻĒā§āϰāϤāĻŋāώā§āĻ āĻžāϤāĻž āĻĄ. āĻŽā§āĻļāϤāĻžāĻ āĻāĻŦāύ⧠āĻā§ā§āĻŦ āĻāĻā§āĻāĻā§āϰāĻžāĻŽā§āϰ āĻāĻŋāύāĻā§ā§ā§āϏā§āĻ āĻāĻŦāĻ āĻšā§ā§āĻžāĻāĻ āĻĢāĻžāĻāύā§āĻĄā§āĻļāύ-āĻāϰ āϝā§āĻĨ āĻāĻĻā§āϝā§āĻā§ āĻā§ā§āĻāĻŋāϤ āĻā§āĻžāϰā§āĻāĻļāĻĒā§ āĻĒā§āϰāĻāύāύ āϏā§āĻŦāĻžāϏā§āĻĨā§āϝ āĻ āĻāϰā§āĻāϧāĻžāϰāĻŖā§āϰ āϏāĻžāĻĨā§ āϏāĻāĻļā§āϞāĻŋāώā§āĻ āĻā§āύā§āĻāĻŋāĻ āĻā§āϏā§āĻ āĻāĻŦāĻ āĻā§āύā§āĻāĻŋāĻ āĻāĻžāĻāύā§āϏā§āϞāĻŋāĻ āĻŦāĻŋāώā§ā§ āĻāύā§āĻāĻžāϰāĻāĻāĻāĻŋāĻ āϏā§āĻļāύ āĻĒāϰāĻŋāĻāĻžāϞāύāĻž āĻāϰā§āύāĨ¤
āĻŽāĻžā§ā§āĻĻā§āϰ āĻāϰā§āĻāϧāĻžāϰāĻŖā§āϰ āĻ
āύā§āĻ āĻŦāĻŋāώ⧠āĻā§āύā§āĻāĻŋāĻāϏ (genetics) āĻĻā§āĻŦāĻžāϰāĻž āύāĻŋā§āύā§āϤā§āϰāĻŋāϤāĨ¤ āĻŦāĻŋāĻļā§āώāϤ āϝāĻžāϰāĻž āĻŦā§āĻļāĻŋ āĻŦā§āϏ⧠āϏāύā§āϤāĻžāύ āĻā§āϰāĻšāĻŖ āĻāϰā§āύ, āϝāĻžāĻĻā§āϰ āĻāϰā§āĻāĻĒāĻžāϤā§āϰ āĻāϤāĻŋāĻšāĻžāϏ āĻāĻā§ āĻāĻŋāĻāĻŦāĻž āĻāύā§āĻŽā§āϰ āĻĒāϰāĻĒāϰāĻ āĻŦāĻžāĻā§āĻāĻž āĻŽāĻžāϰāĻž āϝāĻžā§, āĻāĻŋāĻāĻŦāĻž āĻŽā§āϤ āĻŦāĻžāĻā§āĻāĻž āĻĒā§āϰāϏāĻŦ āĻšā§, āϤāĻžāĻĻā§āϰ āĻā§āύā§āĻāĻŋāĻ āĻā§āϏā§āĻ āĻ āĻā§āύā§āĻāĻŋāĻ āĻāĻžāĻāύā§āϏā§āϞāĻŋāĻ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖāĨ¤
GenePath-āĻāϰ āĻĒāĻā§āώ āĻĨā§āĻā§ āĻāĻŽāύ āĻā§ā§āĻāύ āĻāϰ⧠āĻ
āĻŦā§āϝāĻšāϤ āĻĨāĻžāĻāĻŦā§āĨ¤ āĻĻā§āĻļā§āϰ āĻ
āύā§āϝāĻžāύā§āϝ āĻ
āĻā§āĻāϞā§āĻ āĻā§āĻŋā§ā§ āϝāĻžāĻ āĻ āϏāĻāĻā§āϰāĻžāύā§āϤ āϤāĻĨā§āϝ āĻ āϏā§āĻŦāĻžāĨ¤
22/07/2026
GenePath Founder, Dr. Mustak Ibn Ayub will facilitate a workshop on Genetic Testing and Genetic Counselling in Chattogram, bringing together healthcare professionals and stakeholders to enhance knowledge and practical expertise in this rapidly evolving field.
This initiative reflects Dr. Ayub's continued commitment to expanding awareness, capacity, and professional expertise in genetic testing and genetic counselling across Bangladesh. Through such educational programs, GenePath aims to strengthen the country's capabilities in precision medicine and genomic healthcare.
GenePath looks forward to organizing many more educational workshops and training events across the country in the future.
15/07/2026
Due to high demand from enthusiastic participants outside of Dhaka and abroad, we are hosting this session online.âŖâŖâŖ
âŖâŖâŖ
LifeCourse Presents đđđ§đđđđđĄ đđ§đĨđĸđ§đ đđ¨đĢđ¤đŦđĄđ¨đŠ đ¨đ§ đđđ§đđđĸđ đđđŦđđĸđ§đ & đđđ§đđđĸđ đđ¨đŽđ§đŦđđĨđĨđĸđ§đ âŖâŖâŖâŖ
âŖâŖâŖ
đ
Date & Time: đđ đđŽđĨđ˛ & đ-đ đđŽđ đđđđ || đ:đđ đđ â đđ:đđ đđâŖ
âŖâŖâŖ
đ đđĨđđđđ¨đĢđĻ: Held online via Zoom.âŖâŖâŖ
âŖâŖâŖ
đ¨âđđđ¨đĢđ¤đŦđĄđ¨đŠ đ
đđđĸđĨđĸđđđđ¨đĢ:âŖâŖ
Dr. Mustak Ibn AyubâŖâŖâŖâŖ
âDPhil in Oncology, University of OxfordâŖâŖâŖâŖ
âFellowship in Cancer Genetic Services, National Cancer Centre Singapore (NCCS)âŖâŖâŖâŖ
âAssociate Professor, Dept. of Genetic Engineering & Biotechnology, University of DhakaâŖâŖâŖâŖ
âFounder, GenePath & HealthSynchâŖâŖâŖâŖ
âŖâŖâŖ
đī¸ đđĢđ¨đ đĢđđĻ đđĸđ đĄđĨđĸđ đĄđđŦ:âŖâŖ
đš Lectures on Human Genetics, Genetic Testing & Counselling ApproachesâŖâŖâŖâŖ
đš Case Discussions & Interactive Q&AâŖâŖâŖâŖ
đš Group Work: Research Ideas in Medical GeneticsâŖâŖâŖâŖ
đš Networking & Knowledge SharingâŖâŖâŖâŖ
âŖ
đđŠđđđĸđđĨ đđđđĢđđđđĸđ¨đ§: đđ°đ¯đĩđĒđ¯đļđ°đļđ´ đđĻđ´đĻđĸđŗđ¤đŠ đđ¯đ¨đĸđ¨đĻđŽđĻđ¯đĩ đĸđ¯đĨ đđ°đļđŗđ¯đĸđ đđļđŖđđĒđ¤đĸđĩđĒđ°đ¯ (đđĻđđĻđ¤đĩđĻđĨ đđĸđ¯đĨđĒđĨđĸđĩđĻ)âŖ
âŖâŖâŖ
đ đđ¨đĢđ¤đŦđĄđ¨đŠ đđĸđđŦ:âŖâŖ
â Comprehensive lecture handouts âŖâŖâŖâŖ
â Limited-time access to session recordings (30 days)âŖâŖâŖ
âŖâŖâŖ
đĩ đđđ đĸđŦđđĢđđđĸđ¨đ§ đ
đđđŦ: 2,000 TK for Students || 3,000 TK for ProfessionalsâŖâŖâŖâŖ
âŖâŖâŖ
đ¤ đđĄđ¨ đđĄđ¨đŽđĨđ đđ¨đĸđ§?âŖâŖ
đš Professionals & ResearchersâŖâŖâŖâŖ
đš Students of Biological SciencesâŖâŖâŖâŖ
đš Medical Students & CliniciansâŖâŖâŖâŖ
âŖâŖâŖ
đ đđđ đĸđŦđđĢđđđĸđ¨đ§:âŖâŖ
đ Click Here to Register: https://forms.gle/y2V26y8MofmRrSEc7âŖ
âŖâŖâŖ
Category
Contact the practice
Telephone
Website
Address
1000
Alerts
Be the first to know and let us send you an email when GenePath posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.